The generic prescription drug memantine is also available as brand-name Namenda. It comes in three forms: immediate-release tablet, oral solution, and extended-release capsule. Memantine is prescribed ...

The typical dosage of Namenda (memantine) for dementia related to Alzheimer’s disease is one oral tablet taken twice per day. Your dosing schedule may vary based on factors such as your symptoms and ...

Memantine is approved to treat moderate to severe Alzheimer's disease and other dementias. Evidence suggests that it might also be useful with bipolar disorder, depression, schizophrenia and much more ...

Clinical trials have shown the benefits of cholinesterase inhibitors for the treatment of mild-to-moderate Alzheimer's disease. It is not known whether treatment benefits continue after the ...

August 24, 2010 — The adamantine derivative, memantine, preferentially blocks excessive extrasynaptic activity of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors (NMDAR), while largely ...

The drug memantine can benefit patients with moderate to severe Alzheimer's disease, according to a study reported in the April 3 New England Journal of Medicine. The use of memantine for Alzheimer's ...

The Food and Drug Administration approved the German medication memantine today to help ease the severe symptoms of an estimated 1 million Americans who suffer from the late stages of Alzheimer's ...

In a disappointing turn for Down's syndrome (DS) research, a trial to evaluate potential cognitive benefits of the drug memantine—already used as a treatment in Alzheimer's disease—showed no ...

By Leon Aris in Berlin A small UK-registered biotech company believes it has found an Alzheimer's treatment that is safer, ...

Overstimulation of the N-methyl-D-aspartate (NMDA) receptor by glutamate is implicated in neurodegenerative disorders. Accordingly, we investigated memantine, an NMDA antagonist, for the treatment of ...